Euda Health Holdings Stock Fundamentals
| EUDAW Stock | 0.11 0.02 23.73% |
EUDA Health Holdings fundamentals help investors to digest information that contributes to EUDA Health's financial success or failures. It also enables traders to predict the movement of EUDA Stock. The fundamental analysis module provides a way to measure EUDA Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EUDA Health stock.
At this time, EUDA Health's Depreciation And Amortization is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 5.3 M in 2025, whereas Interest Expense is likely to drop slightly above 19.9 K in 2025. EUDA | Select Account or Indicator |
EUDA Health Holdings Company Revenue Analysis
EUDA Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current EUDA Health Revenue | 3.71 M |
Most of EUDA Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EUDA Health Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of EUDA
Projected quarterly revenue analysis of EUDA Health Holdings provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of EUDA Health match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in EUDA Health's stock price.
EUDA Revenue Historical Pattern
Today, most investors in EUDA Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various EUDA Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of EUDA Health revenue as a starting point in their analysis.
EUDA Health Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
EUDA Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, EUDA Health Holdings reported 3.71 M of revenue. This is 99.95% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 99.96% higher than that of the company.
EUDA Health Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EUDA Health's current stock value. Our valuation model uses many indicators to compare EUDA Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EUDA Health competition to find correlations between indicators driving EUDA Health's intrinsic value. More Info.EUDA Health Holdings is rated below average in return on asset category among its peers. It is rated # 3 in operating margin category among its peers . At this time, EUDA Health's Operating Profit Margin is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value EUDA Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.EUDA Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EUDA Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EUDA Health could also be used in its relative valuation, which is a method of valuing EUDA Health by comparing valuation metrics of similar companies.EUDA Health is currently under evaluation in revenue category among its peers.
EUDA Fundamentals
| Return On Asset | -0.86 | ||||
| Operating Margin | (0.83) % | ||||
| Number Of Shares Shorted | 552 | ||||
| Revenue | 3.71 M | ||||
| Gross Profit | 840.46 K | ||||
| EBITDA | (8.3 M) | ||||
| Net Income | (8.44 M) | ||||
| Total Debt | 3.37 M | ||||
| Book Value Per Share | (0.17) X | ||||
| Cash Flow From Operations | (2.92 M) | ||||
| Number Of Employees | 106 | ||||
| Beta | -0.055 | ||||
| Total Asset | 1.31 M | ||||
| Retained Earnings | (34.74 M) | ||||
| Working Capital | (7.99 M) | ||||
| Net Asset | 1.31 M |
About EUDA Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EUDA Health Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EUDA Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EUDA Health Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 240 K | 252 K | |
| Total Revenue | 3.3 M | 6.6 M | |
| Cost Of Revenue | 2.6 M | 4.1 M | |
| Sales General And Administrative To Revenue | 1.04 | 0.54 | |
| Revenue Per Share | 0.16 | 0.15 | |
| Ebit Per Revenue | (1.23) | (1.29) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for EUDA Stock Analysis
When running EUDA Health's price analysis, check to measure EUDA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EUDA Health is operating at the current time. Most of EUDA Health's value examination focuses on studying past and present price action to predict the probability of EUDA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EUDA Health's price. Additionally, you may evaluate how the addition of EUDA Health to your portfolios can decrease your overall portfolio volatility.